These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10490903)

  • 1. Pharmacokinetics and pharmacodynamics of nifedipine in untreated and atorvastatin-treated hyperlipidemic rats.
    Eliot LA; Jamali F
    J Pharmacol Exp Ther; 1999 Oct; 291(1):188-93. PubMed ID: 10490903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hyperlipidemia on the pharmacokinetics of nifedipine in the rat.
    Eliot LA; Foster RT; Jamali F
    Pharm Res; 1999 Feb; 16(2):309-13. PubMed ID: 10100319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased endothelin-induced Ca2+ signaling, tyrosine phosphorylation, and coronary artery disease in diabetic dyslipidemic Swine are prevented by atorvastatin.
    Lee DL; Wamhoff BR; Katwa LC; Reddy HK; Voelker DJ; Dixon JL; Sturek M
    J Pharmacol Exp Ther; 2003 Jul; 306(1):132-40. PubMed ID: 12663685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics and pharmacokinetic-pharmacodynamic relationships of atorvastatin, an HMG-CoA reductase inhibitor.
    Stern RH; Yang BB; Hounslow NJ; MacMahon M; Abel RB; Olson SC
    J Clin Pharmacol; 2000 Jun; 40(6):616-23. PubMed ID: 10868312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
    Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
    Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats.
    Choi DH; Chang KS; Hong SP; Choi JS; Han HK
    Biopharm Drug Dispos; 2008 Jan; 29(1):45-50. PubMed ID: 17941000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of increased lipoprotein levels on the pharmacokinetics of cyclosporine A in the laboratory rat.
    Brocks DR; Ala S; Aliabadi HM
    Biopharm Drug Dispos; 2006 Jan; 27(1):7-16. PubMed ID: 16278928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat-meal rat models.
    Shayeganpour A; Jun AS; Brocks DR
    Biopharm Drug Dispos; 2005 Sep; 26(6):249-57. PubMed ID: 15968713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients.
    Taylor PJ; Kubler PA; Lynch SV; Allen J; Butler M; Pillans PI
    Ann Pharmacother; 2004 Feb; 38(2):205-8. PubMed ID: 14742751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation.
    Demetriou D; Shabpar A; Böhmig G; Schmaldienst S; Hörl WH; Watschinger B
    Wien Klin Wochenschr; 2000 Apr; 112(8):358-61. PubMed ID: 10849941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-stroke atorvastatin treatment reduces neurological deficits and mortality rate in the stroke-prone spontaneously hypertensive rat.
    Hayashi A; Suzuki M; Ogawa Y; Sonoda R; Sasamata M
    J Pharm Pharmacol; 2004 Jul; 56(7):893-8. PubMed ID: 15233868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihyperlipidemic effect of the methanolic extract from Lagenaria siceraria Stand. fruit in hyperlipidemic rats.
    Ghule BV; Ghante MH; Saoji AN; Yeole PG
    J Ethnopharmacol; 2009 Jul; 124(2):333-7. PubMed ID: 19397976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration.
    Blanco-Colio LM; Martín-Ventura JL; de Teresa E; Farsang C; Gaw A; Gensini G; Leiter LA; Langer A; Martineau P; Egido J;
    Am Heart J; 2007 May; 153(5):881-8. PubMed ID: 17452168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
    Saklamaz A; Comlekci A; Temiz A; Caliskan S; Ceylan C; Alacacioglu A; Yesil S
    Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of nifedipine controlled release on blood pressure and heart rate of spontaneously hypertensive rats. Comparison with nifedipine standard and with amlodipine].
    Di Filippo C; Lampa E; Forgione A; Capuano A; Rossi F; D'Amico M
    Ital Heart J Suppl; 2005 May; 6(5):285-90. PubMed ID: 15934425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.
    Momi S; Impagnatiello F; Guzzetta M; Caracchini R; Guglielmini G; Olivieri R; Monopoli A; Gresele P
    Eur J Pharmacol; 2007 Sep; 570(1-3):115-24. PubMed ID: 17632098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of plasma level of atorvastatin and its effect on lipid profile.
    Valera HR; Ganguly B
    Indian J Physiol Pharmacol; 2009; 53(1):73-82. PubMed ID: 19810580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control.
    Magen E; Viskoper R; Mishal J; Priluk R; Berezovsky A; Laszt A; London D; Yosefy C
    Isr Med Assoc J; 2004 Dec; 6(12):742-6. PubMed ID: 15609886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pharmacokinetic and pharmacodynamic characteristics of foridon during interaction with the metabolic oxidation inhibitor dopegit].
    Kukes VG; Alekhin SN; Rumiantsev AS; Gneushev ET; Gushchin AS; Germanov DV
    Eksp Klin Farmakol; 1993; 56(5):38-41. PubMed ID: 8312808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative effect of fenofibrate and quantitative effect of atorvastatin on LDL profile in combined hyperlipidemia with dense LDL.
    Winkler K; Weltzien P; Friedrich I; Schmitz H; Nickell HH; Hauck P; Hoffmann MM; Baumstark MW; Wieland H; März W
    Exp Clin Endocrinol Diabetes; 2004 May; 112(5):241-7. PubMed ID: 15146369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.